STOCK TITAN

Starling Oncology: Chernett reports roughly 5.6% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Starling Oncology, Inc. (STLN) reports that reporting person Jorey Chernett beneficially owned 5,934,872 shares as of November 13, 2026, equal to approximately 5.6% of the class. The amount consisted of 2,641,272 shares held directly and 3,293,600 shares issuable upon exercise of call options exercisable within 60 days. The option shares are deemed outstanding for the beneficial-ownership calculation.

Beneficial ownership 5,934,872 shares Jorey Chernett's reported amount as of November 13, 2026
Directly held shares 2,641,272 shares Included in Jorey Chernett's reported beneficial ownership
Shares issuable upon call-option exercise 3,293,600 shares Options exercisable within 60 days
Beneficial ownership percentage Approximately 5.6% Percentage of the class reported as of November 13, 2026
beneficially owned regulatory
"beneficially owned 5,934,872 shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
call options financial
"issuable upon exercise of call options"
A call option is a contract that gives its buyer the right, but not the obligation, to buy a specific number of shares at a predetermined price within a set time. Think of it like a refundable reservation to purchase a stock later at today’s agreed price: investors use calls to profit from expected price rises with smaller upfront cost than buying the stock outright, or to hedge and manage exposure, while the most they can lose is the amount paid for the contract.
deemed outstanding regulatory
"deemed outstanding for this purpose"
Rule 13d-3(d)(1)(i) regulatory
"pursuant to Rule 13d-3(d)(1)(i)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did Jorey Chernett beneficially own in STLN?

Jorey Chernett reported beneficial ownership of 5,934,872 shares, approximately 5.6% of the class, as of November 13, 2026. The amount comprised 2,641,272 shares held directly and 3,293,600 shares issuable upon exercise of call options exercisable within 60 days.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





30068X103

(CUSIP Number)
11/13/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (i) 2,641,272 shares of Common Stock held directly by the Reporting Person and (ii) 3,293,600 shares of Common Stock issuable upon exercise of call options held by the Reporting Person that are exercisable within 60 days.


SCHEDULE 13G



Chernett Jorey
Signature:/s/ Jorey Chernett
Name/Title:Chernett Jorey
Date:11/13/2026

Keep reading